Newsroom
Your source for Evernorth news.
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
Estimated to save individual Accredo patients around $4,000 per year
Biosimilar price will be more than 80% lower than Stelara list price
Accredo patients benefit from the specialty pharmacy’s best-in-class clinical support
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (50)
Press Release
Evernorth Puts Affordable, Comprehensive Fertility Benefits In Reach for Millions of Americans With FamilyPath
October 21, 2020
Press Release
Evernorth Continues Work to Reduce Costs and Improve Health With Expanded and Innovative Digital Health Formulary Platform
October 07, 2020
First-in-industry Digital Health Formulary is expanded to better enable people to find effective digital solutions that address their most pressing health care needs